WISCHIK, CLAUDE MICHEL,SCHELTER, BJORN OLAF,WISCHIK, DAMON JUDE,STOREY, JOHN MERVYN DAVID
申请号：
CA3034625
公开号：
CA3034625A1
申请日:
2017.08.25
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The invention describes improved treatments for Frontotemporal dementia based on the use of a methylthioninium compound in combination with a compound which directly modifies synaptic neurotransmission in the brain, such as a symptomatic Alzheimer's disease treatment (e.g. acetylcholinesterase and/or memantine).
